Skip to content

Application of intravenous injection of lidocaine in monitoring anesthesia during intervertebral foramen endoscopy

Application of intravenous injection of lidocaine in monitoring anesthesia during intervertebral foramen endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085979
Enrollment
Unknown
Registered
2024-06-21
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc herniation

Interventions

High dose group:Intravenous injection of lidocaine at a loading dose of 2mg/kg within 20 minutes prior to surgery, followed by maintenance at a dose of 2 mg. kg-1. h-1.
Middle dose group:Intravenous injection of lidocaine at a loading dose of 1mg/kg within 20 minutes prior to surgery, followed by maintenance at a dose of 2 mg. kg-1. h-1.
Low dose group:Intravenous injection of lidocaine at a loading dose of 0.5 mg/kg within 20 minutes prior to surgery, followed by maintenance at a dose of 2 mg. kg-1. h-1.

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who undergo intervertebral foramen endoscopy at Hebei General Hospital, regardless of gender, aged 18-65, have clear awareness and civil capacity, no contraindications to surgery or anesthesia, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal cardiac conduction. 2. Patients with neurological related diseases such as epilepsy. 3. Patients with abnormal liver function. 4. Patients with lidocaine allergy. 5. The patient refused. 6. Patients who experience serious adverse reactions during surgery, terminate the surgery or change the anesthesia method.

Design outcomes

Primary

MeasureTime frame
Bispectral index;Improved Alert/Sedation Rating Scale;Ramsay sedation score;Visual Analogue Scale;

Secondary

MeasureTime frame
Blood pressure;Heart rate ;Pulse oximetry;Respiratory depression;Tachycardia/bradycardia;Nausea and vomiting;rritability and unease;

Countries

China

Contacts

Public ContactZhang Dong

Hebei General Hospital

zhangdongdoctor@126.com+86 151 3060 4037

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026